Solvay's Stock Rebounds to €25.40 but Remains Below Its Moving Averages
This afternoon, the Belgian chemical company stands out on the Parisian market. The stock is gaining ground after a more than 8% decline over three months, in an SBF 120 that is up 0.30%. The rebound occurs despite a charged sectoral context, marked by a surge in Brent and rising bond yields.
Solvay Among the Top Gainers in the SBF 120 Mid-Afternoon
Solvay's stock is up 2.58% to €25.40, after closing at €24.76 last. This increase places the stock among the top gainers in the SBF 120, behind Teleperformance (+6.2%), Publicis (+4.41%), and Sartorius Stedim Biotech (+3.78%). The rebound occurs in a contrasting market environment. The CAC 40 is up 0.36% at 7,981 points, supported by cyclical stocks, while the Nasdaq was down 1.54% at the last available indication. Against a backdrop of Brent above $110 and the rise in the yield of the US Treasury to 4.63%, these continue to weigh on assets sensitive to energy costs and financing. The movement today mitigates some of the recent downward dynamics. The stock remains at -3.35% for the week and -15.33% for the year. It follows the rebound that began last week, after the post-results downturn on May 7, already discussed during the stock's recovery to €27.32.
The Price Breaks Below the Lower Bollinger Band Indicating Technical Overselling
Free · Every morning
Technical market signals, before the opening bell.
Bullish and bearish momentum, analyst changes, stocks to watch — automatically computed from Euronext data.
✓ Before 9 AM every morning✓ Euronext data✓ AI-powered analysis
You're in — subscription confirmed!
Your first edition is on its way. Check your spam folder and add us to your contacts.
An error occurred.
Indicative data. No investment advice. Unsubscribe at any time.
Gratuit · chaque matin
Ne ratez plus rien sur vos actions
La tendance derrière les cours. L'essentiel des valeurs Euronext en quelques minutes.
📈les valeurs en mouvement, sur la durée
🎯les objectifs d'analystes qui évoluent
📰les actualités qui font bouger les cours
tendance · 6 séances
✓ C'est fait, vous êtes inscrit !
Votre première édition arrive bientôt. Pensez à vérifier vos spams.
Une erreur est survenue.
CAC 40 · SBF 120 · données indicatives · aucun conseil en investissement · désinscription à tout moment.
In terms of indicators, the situation remains tense despite the rebound. The price at €25.40 is below the lower Bollinger Band set at €26.11, indicating a potential overselling situation following the decline of the last two weeks. The RSI at 42 remains in the neutral zone, without crossing any thresholds. The stock also remains below its three moving averages, with a gap of 7.33% below the MM20 (€27.41) and 6.38% below the MM200 (€27.13). The support threshold identified at €26.22 has not been reclaimed during the session, with the price staying below it despite today's rise. Regarding news, the first quarter accounts published on May 7 had weighed heavily on the stock, with the company then mentioning a volatile external environment and focusing on cash generation. The next financial calendar event is the publication of the semi-annual results for 2026, scheduled for July 29.
Challenging market environment, excluding potential recovery measures from Sadara, updated guidance reflects Middle East impact
Risks mentioned
Middle East conflict impact of approximately €-25 million on underlying EBITDA in Q3 2026
Continued shutdown of the Peroxide plant at the Sadara complex in Jubail, Saudi Arabia accounted for €-15 million in Q3 2026
Challenging market environment affecting Group performance in Q3 2026
Opportunities identified
Joint venture contractual framework includes mechanisms designed to recover lost profitability from Sadara shutdown
Group exploring all available avenues to mitigate financial impact of shutdown
Transformation program and focus on cash generation and cost savings targets
Outlook / guidance
Expected EBITDA: 730 millions d'euros
Management commentary: In light of these developments, Solvay has reviewed its full-year 2026 guidance. Excluding potential revenue or recovery measures from Sadara for the remainder of 2026, the updated guidance is: Underlying EBITDA between €720 and €740 million
The information presented in this article is provided for informational purposes only and does not constitute an investment recommendation, an incentive to buy or sell a financial asset, or investment advice. Readers are invited to conduct their own research before making any decision.
Investments in the stock market involve risks, including the risk of capital loss. Past performance of an asset or market is no guarantee of future results. Any investment decision should be made taking into account your personal financial situation, objectives and risk tolerance.